Revelation Biosciences, Inc.

REVBNASDAQHealthcare● Active

$1.01

+$0.02(+2.02%)

Market Cap$3947504

P/E Ratio—

52W High$12.88

52W Low$0.875

Avg Volume71K

Open$1.01

Beta-0.08

Cash on Hand Financials Revenue

Revelation Biosciences, Inc. (REVB) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

REVB · cash on hand · updated Dec 31, 2025

Core cash position

as of Dec 31, 2025

Cash & Short-Term Investments (CCE + ST Investments)

$10.7M▲ +64.6% vs prior year

FY · as of Dec 31, 2025 · Reported in USD

Cash & Cash Equiv. (CCE)

$10.7M

cashAndCashEquivalents

Short-Term Investments

shortTermInvestments

YoY Change vs Prior Year

+64.6%

vs prior fiscal year

Latest Quarter

$14.1M

Q1 2026

Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash vs Debt · Balance Sheet Health

Cash & ST Investments$10.7MCash on Hand

Total Debt$746,784Total Debt

Net Cash / Net Debt+$10.0MNet Cash Position

Cash vs Debt Ratio

Cash 93%Revelation Biosciences, Inc. cash as % of market cap: 271.07%% · MCap $0BDebt 7%

Revelation Biosciences, Inc. has a net cash position of $10.0M, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$10.7M − $746,784 = +$10.0M

Cash on hand history

annual cash on hand trend · Cash & Short-Term Investments

YoY Increase

YoY Decrease

Latest Year

REVB annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

REVB cash & short-term investments history

DatePeriodCash & ST InvestmentsYoY Change

Dec 31, 2025LatestFY$10.7M+64.6%

Dec 31, 2024FY$6.5M-45.8%

Dec 31, 2023FY$12.0M+128.3%

Dec 31, 2022FY$5.3M+312.1%

Dec 31, 2021FY$1.3M-71.6%

REVB cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

REVB vs peers · cash on hand

#CompanyCash & ST Inv.Market CapCash/MCapRelative

UnitedHealth Group Incorporated

Eli Lilly and Company

Revelation Biosciences, Inc.YOU

REVB

$10.7M$4M271.1%

Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Revelation Biosciences, Inc. (REVB) cash on hand as of December 31, 2025 is $10.7M, comprising $10.7M in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as Revelation Biosciences, Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as Revelation Biosciences, Inc. cash reserves or cash position.

Revelation Biosciences, Inc. annual cash on hand history shows increased +64.6% in 2025: increased +64.6% in 2025. Revelation Biosciences, Inc. cash reserves in 2025 reflect the company's capital allocation strategy.

Revelation Biosciences, Inc. carries total debt of $746,784 against cash of $10.7M, resulting in a net cash position of +$10.0M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Financial statements Free cash flow Net income Revenue Market cap P/E ratio Earnings Price history

Frequently asked questions

REVB cash on hand · 5 questions

As of December 31, 2025, Revelation Biosciences, Inc. (REVB) has $10,700,331 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $10,700,331 in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (March 31, 2026): $14,113,415. Data sourced from the annual 10-K filing via FMP.

REVB cash on handREVB cash reservesREVB cash 2025how much cash does REVB have

▸ Source: FMP /balance-sheet-statement · US GAAP · Revelation Biosciences, Inc. · Revelation Biosciences, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025